SYNI — Synvista Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Synvista Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2003 December 31st	2004 December 31st	2005 December 31st	C2006 December 31st	2007 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	—	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.7	11.2	6.58	1.48	15.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	16.9	11.3	6.8	1.79	15.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.102	0.108	0.056	0.012	0.018
Other Long Term Assets
Total Assets	17.3	11.6	7.13	2.31	16.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.87	2.6	1.14	1.06	2.84
Total Long Term Debt
Total Debt
Total Liabilities	1.87	2.6	1.14	1.06	2.84
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	15.4	9.05	5.99	1.24	13.9
Total Liabilities & Shareholders' Equity	17.3	11.6	7.13	2.31	16.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding